| Enriched cancer pathway | Genes under regulation | P value |
|---|
| MAPK signaling pathway |
8 genes: GADD45G, DUSP8, GNA12, GADD45B, PRKCA, SOS1, SRF, CACNA1C
|
0.002632 |
| GnRH signaling pathway |
4 genes: PRKCA, SOS1, CACNA1C, CAMK2G
|
0.01222 |
| Melanogenesis |
4 genes: GNAO1, PRKCA, CREB3L2, CAMK2G
|
0.01222 |
| Glycosaminoglycan biosynthesis . chondroitin sulfate |
2 genes: XYLT1, CHST3
|
0.01585 |
| Vascular smooth muscle contraction |
4 genes: KCNMB4, GNA12, PRKCA, CACNA1C
|
0.01937 |
| Dorso.ventral axis formation |
2 genes: NOTCH2, SOS1
|
0.02023 |
| Long.term potentiation |
3 genes: PRKCA, CACNA1C, CAMK2G
|
0.02385 |
| Long.term depression |
3 genes: GNA12, GNAO1, PRKCA
|
0.02385 |
| Fc epsilon RI signaling pathway |
3 genes: PRKCA, SOS1, GAB2
|
0.03255 |
| Regulation of actin cytoskeleton |
5 genes: PIP5K1C, CYFIP2, GNA12, ITGB3, SOS1
|
0.04108 |
| ErbB signaling pathway |
3 genes: PRKCA, SOS1, CAMK2G
|
0.04149 |